was held at Soul Cycle, Bronxville, NY on Sunday, March 19th. A special thank you to Phil Gormley, who has organized this event since the beginning! Thank you for all you have done. Thank you for all who’ve participated from year one to now year 10, (unbelievable)… You are the constant warriors in the WarOnALS®. Only by making a continuous and concerted effort through “research” on all levels, will this “hideous disease-ALS” be destroyed.
Today (March 16) your support goes 10x as far! Amazon is celebrating its #1 ranking in customer satisfaction by the ACSI! Today, March 16, Amazon will donate 5% (10 times the usual donation rate) of the price of your eligible AmazonSmile purchases to Blazeman Foundation for ALS. Get started at smile.amazon.com/ch/20-8526311.
The Mulligan Lab is currently completing treatments of the SOD1G93A mouse model of ALS with four different doses of the Hsp70 protein and hopes to have the dose response study complete by the end of March/mid-April. With positive results (hopefully), our ALS scientists and clinicians will begin to design initial clinical trials in patients.
This Holiday Season (or anytime of year) if you shop Amazon, then the AmazonSmile Foundation will donate 0.5% of the purchase price from your eligible purchases. Click Blazeman Foundation for ALS for a direct link.
An update on the Hsp70 research being conducted in the Milligan lab and how your donations are contributing to the future success in the WarOnALS.
Blazeman postdoctural fellow, Dr. Mugdha Deshpande working with others in the lab of Dr. Rodal at Brandeis University found and fixed an abnormality in flies’ nervous system, restoring their ability to crawl. Understanding what goes wrong inside nerve cells could have implications for human disease.
The Blazeman Foundation for ALS support at Brandeis is critical to the efforts of ALS research and to training the next generation of ALS researchers.
Update on the third year of research supported by the Blazeman Foundation for ALS to the Rodal Lab that resulted in a primary research article (currently under peer review), as well as a published review article.